Itemgroups: Type of functioning organ transplant,Most recent transplantation,Immunsuppression at diagnosis of SARS-CoV-2,Graft status before COVID-19,Therapeutic measures of transplant specific therapy,Is data entry for this section finished?

Itemgroups: Clinical phase of CMR diagnostic,CMR Indication,CMR context,Patient's characteristics,Heart Rhythm,CMR procedure completed,MRI: Delayed contrast enhancement,CMR measurements,Mapping results,Edema T2 on T2-weighted imaging,Wall motion abnormalities,Perfusion deficit during stress testing,Pericardium,Myocardial strain,Assessment,CMR: Additional information,CMR_completed

Itemgroups: Antibodies: Anti-CD20,Antibodies: CD-22,Antibodies: CD-38,Antibodies: CD-52,Antibodies: Anti-CD79b,Antibodies: BLyS,Antibodies: CD19-BiTE,Antibodies: Complement inhibitors,Antibodies: Integrin antagonists,Antibodies: Interleukin inhibitors,Antibodies: TNF-alpha inhibitors,Other Antibodies,Inhibitors: Co-stimulation inhibitors,Inhibitors: Calcineurin inhibitors,Inhibitors: Interleukin inhibitor,Inhibitors: JAK inhibitors,Inhibitors: mTOR inhibitors,Inhibitor: PDE-4-inhibitor,Other Inhibitors,Recent: Checkpoint inhibitors,Chemotherapeutics: Antimetabolites,Chemotherapeutics: Cytostatics,Other Chemotherapeutics,Corticosteroids,Other immunosuppressive regimens: Fumarate,Other immunosuppressive regimens: Immunoglobulines,Other immunosuppressive regimens: Interferon,Immunosuppressive regimens: Other Multiple Sclerosis drugs,Other immunosuppressive regimens,Immunosuppressive drugs: Underlying disease,Is data entry for this section finished?

Itemgroups: Underlying disease: Hematological diseases,Solid tumors,Other underlying diseases,NHL,Time of first diagnosis,BL (Oncological status),Prior anti-cancer therapy,Stem cell transplantation,Hypogammaglobuliaemia,Is data entry for this section finished?

Itemgroups: Etiology of liver cirrhosis,Hepatic decompensation (Ascites, Variceal bleeding, Hepatic encephalopathy),Reasons of consultation / hospitalisation,Liver transplantation waiting list,Recent bacterial infection,Child-Pugh Score at Baseline,MELD Score,Acute-on-chronic liver failure during the SARS-CoV-2 infection,Recent medication,Is data entry for this section finished?

Itemgroups: Type of CIM in uncomplicated phase,Type of CIM in complicated phase,Type of CIM in critical phase,Type of CIM in recovery phase,Other type of CIM,Food supplements: Before SARS-CoV-2 detection,Food supplements: After SARS-CoV detection,Application type of CIM intervention,Lifestyle interventions,Is data entry for this section finished?

Itemgroups: Type of apheresis therapy,Apharesis start in disease phase,Apharesis treatment details,Is data entry for this section finished?

Itemgroups: HIV transmission risk,Current antiretroviral therapy,Antiretroviral therapy duration before SARS-CoV-2 detection,Antiretroviral therapy changed / started during SARS-Cov-2 infection,Antiretroviral therapy regimen at end of follow-up period,CD4+ T-cell count (abs.),CD4+ T-cell count (rel.),HIV CDC stage at baseline,CD8+ T-cell count (abs.),CD8+ T-cell count (rel.),HIV viral load,Opportunistic infections, AIDS-defining illnesses, STI during COVID-19,Is data entry for this section finished?

Itemgroups: Rheumatic disease,Organ manifestations,Rheumatic disease duration,Is data entry for this section finished?

Itemgroups: Participant Identification Numbers,ICU/HDU Admission Form,Reason for ICU admission,Fraility and renal failure,Daily form,Current treatment

Itemgroups: Participant Identification Numbers,Current treatment,Signs and Symptoms

Itemgroups: Participant Identification,Q1. Status on admission,Q2. Previous obstetric history,Q3. Delivery,Were any of the following samples tested?,Q4. Neonate Details (If multiple pregnancy complete Q4 for each baby)